Recombinant adeno-associated viral (rAAV) vectors have emerged as the leading gene delivery platform for gene therapy and genetic vaccination. For this promising gene delivery vector to fully realize its therapeutic or prophylactic potential, a rational design strategy is desired. The current challenges in viral vector manufacturing robustness, scale up, and productivity will need to be addressed to turn this mode of treatment into an accessible global benefit. To meet this goal, reliable analytical technologies to help establish a structure-function relationship, guide the development of manufacturing processes, and assess the quality of clinical materials have become increasingly relevant and urgent.
In this upcoming webinar, hear from Ximo Zhang, Senior Scientist at Waters, to discover the challenges associated with analyzing AAV samples, and discover how LC and LC-MS workflows can help solve these setbacks, including those that employ size-exclusion chromatography (SEC), anion-exchange chromatography (AEX), protein reversed phase LC-MS, and peptide mapping LC-MS based analyses.
Watch this webinar to learn:
Who should attend?
Certificate of attendance
All webinar participants can request a certificate of attendance, and a learning outcomes summary document for continuing education purposes.
This webinar will run at two different times. The first session will be on Monday, September 28, at:
The second session will run on Tuesday, September 29, at:
SelectScience runs more than 10 webinars a month across various scientific topics, discover more of our webinars here>>